Corrigendum to 'A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer' Eur J Cancer 2001, 37, S264-S265. R. Pirker, J. Vansteenkiste, J. Gateley, P. Yates, A. Colowick, J. Musil

Author:  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.3, 2002-01, pp. : 449-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content